新加坡ASLAN Pharma
ASLAN總部位于新加坡,是面向全球市場研發新型藥物的醫藥公司。ASLAN從全球醫藥公司引進臨床前和臨床分子,專注于腫瘤、呼吸道和炎癥性疾病。ASLAN充分利用中國、韓國、澳大利亞及新加坡等國的資源,高效地將候選藥物投入臨床研究,并計劃與醫藥公司合作,共同完成晚期全球研發和市場化。
ASLAN is an Asia enabled pharmaceutical company that develops novel medicines for global markets.
ASLAN inlicenses preclinical drugs that are up to 6-12 months from the clinic
ASLAN uses its own financial resources and high quality CRO facilities to perform preclinical, Phase 1 and 2 studies on the partnered compounds
ASLAN gets Proof of Concept (PoC) for the partnered compounds in Asia
ASLAN outlicenses PoC compounds back to partner for global development and launch